A new Phase I clinical trial from London Health Sciences Centre Research Institute (LHSCRI) has found that high-precision ...
Shares of GH Research climbed after the company said it would provide data from a trial of its drug for treatment-resistant depression. The stock rose 5.2%, to $11.15, in after-hours trading on Friday ...
A new study from Moffitt Cancer Center could help doctors predict how well patients with a specific type of lung cancer will ...
Astronomers studying FCC 224, an ultra-diffuse galaxy, have discovered luminous, overmassive globular clusters, providing key ...
Today's medical AI systems represent not just a new diagnostic tool, but a new kind of medical reasoning altogether, writes ...
The age of targeted cancer therapies brings the potential for more treatment options, greater effectiveness and fewer side effects.